191 related articles for article (PubMed ID: 20518069)
1. Mitotic drug targets.
Kaestner P; Bastians H
J Cell Biochem; 2010 Oct; 111(2):258-65. PubMed ID: 20518069
[TBL] [Abstract][Full Text] [Related]
2. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs.
Schmidt M; Bastians H
Drug Resist Updat; 2007; 10(4-5):162-81. PubMed ID: 17669681
[TBL] [Abstract][Full Text] [Related]
3. How do anti-mitotic drugs kill cancer cells?
Gascoigne KE; Taylor SS
J Cell Sci; 2009 Aug; 122(Pt 15):2579-85. PubMed ID: 19625502
[TBL] [Abstract][Full Text] [Related]
4. Emerging mitotic inhibitors for non-small cell carcinoma.
Casaluce F; Sgambato A; Maione P; Ciardiello F; Gridelli C
Expert Opin Emerg Drugs; 2013 Mar; 18(1):97-107. PubMed ID: 23448156
[TBL] [Abstract][Full Text] [Related]
5. Targeting mitosis for anti-cancer therapy.
Sudakin V; Yen TJ
BioDrugs; 2007; 21(4):225-33. PubMed ID: 17628120
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale.
Komlodi-Pasztor E; Sackett DL; Fojo AT
Clin Cancer Res; 2012 Jan; 18(1):51-63. PubMed ID: 22215906
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Antimitotic drugs in cancer chemotherapy: promises and pitfalls.
Marzo I; Naval J
Biochem Pharmacol; 2013 Sep; 86(6):703-10. PubMed ID: 23886991
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
[TBL] [Abstract][Full Text] [Related]
10. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
Kim SN; Kim NH; Park YS; Kim H; Lee S; Wang Q; Kim YK
Biochem Pharmacol; 2009 Jun; 77(12):1773-9. PubMed ID: 19428332
[TBL] [Abstract][Full Text] [Related]
11. Anti-mitotic agents: Are they emerging molecules for cancer treatment?
Penna LS; Henriques JAP; Bonatto D
Pharmacol Ther; 2017 May; 173():67-82. PubMed ID: 28174095
[TBL] [Abstract][Full Text] [Related]
12. Mitosis-targeting natural products for cancer prevention and therapy.
Rao CV; Kurkjian CD; Yamada HY
Curr Drug Targets; 2012 Dec; 13(14):1820-30. PubMed ID: 23140292
[TBL] [Abstract][Full Text] [Related]
13. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.
Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D
Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625
[TBL] [Abstract][Full Text] [Related]
14. Advances in mitotic inhibitors for cancer treatment.
Jiang N; Wang X; Yang Y; Dai W
Mini Rev Med Chem; 2006 Aug; 6(8):885-95. PubMed ID: 16918495
[TBL] [Abstract][Full Text] [Related]
15. Clinical Development of Anti-mitotic Drugs in Cancer.
Olziersky AM; Labidi-Galy SI
Adv Exp Med Biol; 2017; 1002():125-152. PubMed ID: 28600785
[TBL] [Abstract][Full Text] [Related]
16. 4'-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3',4',5'-substituted)anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents.
Jin Y; Zhou ZY; Tian W; Yu Q; Long YQ
Bioorg Med Chem Lett; 2006 Nov; 16(22):5864-9. PubMed ID: 16942876
[TBL] [Abstract][Full Text] [Related]
17. Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.
Harrison MR; Holen KD; Liu G
Clin Adv Hematol Oncol; 2009 Jan; 7(1):54-64. PubMed ID: 19274042
[TBL] [Abstract][Full Text] [Related]
18. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
Henriques AC; Ribeiro D; Pedrosa J; Sarmento B; Silva PMA; Bousbaa H
Cancer Lett; 2019 Jan; 440-441():64-81. PubMed ID: 30312726
[TBL] [Abstract][Full Text] [Related]
19. The mitotic checkpoint in cancer therapy.
Tao W
Cell Cycle; 2005 Nov; 4(11):1495-9. PubMed ID: 16258280
[TBL] [Abstract][Full Text] [Related]
20. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
